These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29231142)

  • 1. CRISPR-Cas in Medicinal Chemistry: Applications and Regulatory Concerns.
    Duardo-Sanchez A
    Curr Top Med Chem; 2017; 17(30):3308-3315. PubMed ID: 29231142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
    Bellver Capella V
    Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CRISPR/Cas: technique to repair DNA errors: is a clinical breakthrough near?].
    van de Vrugt HJ; Cornel MC; Wolthuis RMF
    Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cpf1: A New Tool for Plant Genome Editing.
    Zaidi SS; Mahfouz MM; Mansoor S
    Trends Plant Sci; 2017 Jul; 22(7):550-553. PubMed ID: 28532598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Starting the conversation: CRISPR's role in India.
    Udwadia F; Singh S
    Indian J Med Ethics; 2019; 4 (NS)(4):300-303. PubMed ID: 31213419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR and the Law: A South African Perspective.
    Soni S
    CRISPR J; 2020 Apr; 3(2):81-82. PubMed ID: 32315223
    [No Abstract]   [Full Text] [Related]  

  • 7. The morality and ethics governing CRISPR-Cas9 patents in China.
    Peng Y
    Nat Biotechnol; 2016 Jun; 34(6):616-8. PubMed ID: 27281418
    [No Abstract]   [Full Text] [Related]  

  • 8. Legal issues regarding gene editing at the beginning of life: an EU perspective.
    De Miguel Beriain I
    Regen Med; 2017 Sep; 12(6):669-679. PubMed ID: 28976851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology.
    Grant EV
    Food Drug Law J; 2016; 71(4):608-33. PubMed ID: 29140647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thinking About CRISPR: The Ethics of Human Genome Editing.
    Barrangou R
    CRISPR J; 2019 Oct; 2(5):247-248. PubMed ID: 31599676
    [No Abstract]   [Full Text] [Related]  

  • 12. A CRISPR Moratorium Isn't Enough: We Need a Boycott.
    Hough SH; Ajetunmobi A
    CRISPR J; 2019 Dec; 2(6):343-345. PubMed ID: 31860353
    [No Abstract]   [Full Text] [Related]  

  • 13. The better edge of the CRISPR blade.
    The Lancet
    Lancet; 2020 Jan; 395(10218):90. PubMed ID: 31929016
    [No Abstract]   [Full Text] [Related]  

  • 14. Human Genome Editing and Ethical Considerations.
    Krishan K; Kanchan T; Singh B
    Sci Eng Ethics; 2016 Apr; 22(2):597-9. PubMed ID: 26154417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comments on the CRISPR Gene-edited babies' case.
    Cong Y
    Indian J Med Ethics; 2019; 4 (NS)(4):297-300. PubMed ID: 31791938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.
    Lin J; Zhou Y; Liu J; Chen J; Chen W; Zhao S; Wu Z; Wu N
    J Cell Biochem; 2017 Oct; 118(10):3061-3071. PubMed ID: 28590031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR technologies for bacterial systems: Current achievements and future directions.
    Choi KR; Lee SY
    Biotechnol Adv; 2016 Nov; 34(7):1180-1209. PubMed ID: 27566508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas in Arabidopsis: overcoming challenges to accelerate improvements in crop photosynthetic efficiencies.
    Khumsupan P; Donovan S; McCormick AJ
    Physiol Plant; 2019 May; 166(1):428-437. PubMed ID: 30706492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.